Altered Expression of Key Players in Vitamin D Metabolism and Signaling in Malignant and Benign Thyroid Tumors

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 7, 2012, Pages 502-511

  Clinckspoor, Isabelle ^a   Hauben, Esther ^b   Verlinden, Lieve ^a   van den Bruel, Annick ^a   Vanwalleghem, Lieve ^c   Vander Poorten, Vincent ^b   Delaere, Pierre ^b   Mathieu, Chantal ^b   Verstuyf, Annemieke ^c   Decallonne, Brigitte ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c General Hospital St Jan   (Belgium)

Author keywords

cancer; thyroid; VDR; vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; MESSENGER RNA; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ANAPLASTIC THYROID CANCER; ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID TUMOR; VITAMIN D METABOLISM; BIOSYNTHESIS; GENETICS; METABOLISM; PATHOLOGY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; HUMANS; RECEPTORS, CALCITRIOL; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROID HYDROXYLASES; THYROID NEOPLASMS; VITAMIN D;

EID: 84865838525     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412447296     Document Type: Article

References (27)

1. Agic A,Xu H,Altgassen C,Noack F,Wolfler MM,Diedrich K,Friedrich M,Taylor RN,Hornung D.Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers.Reprod Sci. 2007;14:486-497.
2. Blomberg JM,Andersen CB,Nielsen JE,Bagi P,Jorgensen A,Juul A,Leffers H.Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.J Steroid Biochem Mol Biol. 2010;121:376-382.
3. Bouillon R,Eelen G,Verlinden L,Mathieu C,Carmeliet G,Verstuyf A.Vitamin D and cancer.J Steroid Biochem Mol Biol. 2006;102:156-162.
4. Clinckspoor I,Verlinden L,Overbergh L,Korch C,Bouillon R,Mathieu C,Verstuyf A,Decallonne B.1,25- Dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer.J Steroid Biochem Mol Biol. 2011;124:1-9.
5. Cross HS,Bajna E,Bises G,Genser D,Kallay E,Potzi R,Wenzl E,Wrba F,Roka R,Peterlik M.Vitamin D receptor and cytokeratin expression be progression indicators in human colon cancer.Anticancer Res. 1996;16:2333-2337.
6. Dackiw AP,Ezzat S,Huang P,Liu W,Asa SL.Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer.Endocrinology. 2004;145:5840-5846.
7. AJCC cancer staging manual. 2010. AJCC cancer staging manual. 7th ed.New York: Springer.Edge SBByrd DRCompton CCFritz AGGreene FLTrotti A, ed. New York: Springer; 2010:.
8. Giovannucci E,Liu Y,Rimm EB,Hollis BW,Fuchs CS,Stampfer MJ,Willett WC.Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.J Natl Cancer Inst. 2006;98:451-459.
9. Horvath HC,Lakatos P,Kosa JP,Bacsi K,Borka K,Bises G,Nittke T,Hershberger PA,Speer G,Kallay E.The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis.J Histochem Cytochem. 2010;58:277-285.
10. Khadzkou K,Buchwald P,Westin G,Dralle H,Akerstrom G,Hellman P.25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.J Histochem Cytochem. 2006;54:355-361.
11. Khoo ML,Beasley NJ,Ezzat S,Freeman JL,Asa SL.Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.J Clin Endocrinol Metab. 2002;87:1814-1818.
12. Kondo T,Ezzat S,Asa SL.Pathogenetic mechanisms in thyroid follicular-cell neoplasia.Nat Rev Cancer. 2006;6:292-306.
13. Kostner K,Denzer N,Muller CS,Klein R,Tilgen W,Reichrath JAnticancer Res. 2009:3511-3536.
14. Liu W,Asa SL,Ezzat S.1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.Mol Endocrinol. 2005;19:2349-2357.
15. Liu W,Asa SL,Fantus IG,Walfish PG,Ezzat S.Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.Am J Pathol. 2002;160:511-519.
16. Liu W,Tretiakova M,Kong J,Turkyilmaz M,Li YC,Krausz T.Expression of vitamin D3 receptor in kidney tumors.Hum Pathol. 2006;37:1268-1278.
17. Lopes N,Sousa B,Martins D,Gomes M,Vieira D,Veronese LA,Milanezi F,Paredes J,Costa JL,Schmitt F.Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.BMC Cancer. 2010;10:483.
18. Lurie G,Wilkens LR,Thompson PJ,McDuffie KE,Carney ME,Terada KY,Goodman MT.Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.Cancer Epidemiol Biomarkers Prev. 2007;16:2566-2571.
19. MangelsdorfTJ. 2005. Tissue-specific expression patterns of nuclear receptors. www.nursa.org/10.1621/datasets.02001.
20. McCarthy K,Laban C,Bustin SA,Ogunkolade W,Khalaf S,Carpenter R,Jenkins PJ.Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue.Anticancer Res. 2009;29:155-157.
21. Segersten U,Holm PK,Bjorklund P,Hessman O,Nordgren H,Binderup L,Akerstrom G,Hellman P,Westin G.25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.Breast Cancer Res. 2005;7:R980-R986.
22. Sharma V,Fretwell D,Crees Z,Kerege A,Klopper JP.Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism.Thyroid. 2010;20:1103-1111.
23. Sherman SI.Thyroid carcinoma.Lancet. 2003;361:501-511.
24. Silvagno F,Poma CB,Realmuto C,Ravarino N,Ramella A,Santoro N,D'Amelio P,Fuso L,Pescarmona G,Zola P.Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer.Gynecol Oncol. 2010;119:121-124.
25. Stojadinovic A,Shoup M,Nissan A,Ghossein RA,Shah JP,Brennan MF,Shaha AR.Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence.Ann Surg Oncol. 2002;9:789-798.
26. Wada K,Tanaka H,Maeda K,Inoue T,Noda E,Amano R,Kubo N,Muguruma K,Yamada N,Yashiro M, et al.Vitamin D receptor expression is associated with colon cancer in ulcerative colitis.Oncol Rep. 2009;22:1021-1025.
27. Zinser GM,Suckow M,Welsh J.Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues.J Steroid Biochem Mol Biol. 2005;97:153-164.